German LION bioscience has launched an integration platform that aims to speed up drug discovery by integrating cross-functional information from a variety of databases and applications.
The company said that the German pharmaceutical company Bayer is on board as a customer and will use the LION DiscoveryCenter platform for parts of its PIx (Pharmacophore Informatics) cheminformatics project managed by LION. Apparently a LION DiscoveryCenter installation is already underway at Schering in Berlin.
"We are confident LION DiscoveryCenter will become the standard discovery platform in the life science industry, just as SRS has become the standard for integrating biological information," said LION bioscience CEO Friedrich von Bohlen.
In a statement LION bioscience make reference to a recent study of the pharmaceutical industry by the Boston Consulting group that found two of the most difficult areas in drug discovery are the integration of data and applications as well as the sharing of that information throughout the rest of the enterprise.